Deciphera Pharmaceuticals Inc (DCPH)
25.38
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
25.37
-0.01
(-0.04%)
After-Hours: 20:00
Deciphera Pharmaceuticals Price to Book Value: 5.844 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 5.844 |
| May 02, 2024 | 5.844 |
| May 01, 2024 | 5.839 |
| April 30, 2024 | 5.818 |
| April 29, 2024 | 5.821 |
| April 26, 2024 | 3.373 |
| April 25, 2024 | 3.265 |
| April 24, 2024 | 3.366 |
| April 23, 2024 | 3.378 |
| April 22, 2024 | 3.357 |
| April 19, 2024 | 3.378 |
| April 18, 2024 | 3.276 |
| April 17, 2024 | 3.389 |
| April 16, 2024 | 3.417 |
| April 15, 2024 | 3.431 |
| April 12, 2024 | 3.465 |
| April 11, 2024 | 3.574 |
| April 10, 2024 | 3.594 |
| April 09, 2024 | 3.601 |
| April 08, 2024 | 3.456 |
| April 05, 2024 | 3.532 |
| April 04, 2024 | 3.486 |
| April 03, 2024 | 3.521 |
| April 02, 2024 | 3.498 |
| April 01, 2024 | 3.629 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.622 |
| March 27, 2024 | 3.495 |
| March 26, 2024 | 3.412 |
| March 25, 2024 | 3.523 |
| March 22, 2024 | 3.507 |
| March 21, 2024 | 3.569 |
| March 20, 2024 | 3.626 |
| March 19, 2024 | 3.447 |
| March 18, 2024 | 3.419 |
| March 15, 2024 | 3.590 |
| March 14, 2024 | 3.663 |
| March 13, 2024 | 3.680 |
| March 12, 2024 | 3.705 |
| March 11, 2024 | 3.808 |
| March 08, 2024 | 3.900 |
| March 07, 2024 | 3.898 |
| March 06, 2024 | 3.898 |
| March 05, 2024 | 3.868 |
| March 04, 2024 | 3.824 |
| March 01, 2024 | 3.997 |
| February 29, 2024 | 3.843 |
| February 28, 2024 | 3.871 |
| February 27, 2024 | 3.894 |
| February 26, 2024 | 3.785 |
| February 23, 2024 | 3.698 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.184
Minimum
Nov 29 2021
8.546
Maximum
Aug 28 2019
3.765
Average
3.630
Median
Mar 17 2020
Price to Book Value Benchmarks
| Bristol-Myers Squibb Co | 5.408 |
| Dynavax Technologies Corp | 2.465 |
| Gilead Sciences Inc | 4.628 |
| Esperion Therapeutics Inc | -- |
| SINTX Technologies Inc | 0.6559 |
Price to Book Value Related Metrics
| PS Ratio | 13.21 |
| Price | 25.38 |
| Earnings Yield | -9.02% |
| Market Cap | 2.051B |